Accelerating Access for Patients Act of 2022
Summary
Accelerating Access for Patients Act of 2022 This bill modifies requirements relating to accelerated approval of drugs for serious or life-threatening diseases or conditions, including by requiring guidance from the Food and Drug Administration and coordinated plans with product sponsors on appropriate postapproval studies.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2022
Committee Review
Floor Vote
President
Introduced Mar 8, 2022
Last action Mar 9, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Mar 9, 2022
Committee
Referred to the Subcommittee on Health.
lower
Mar 8, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Mar 8, 2022
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Cathy McMorris Rodgers
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6996
Scope: US
Hi! I can help you understand HR 6996. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline